Covishield Export Resumes, Serum Institute Crosses 1 Billion Vaccine Mark
Covishield-maker Serum Institute of India has resumed vaccine exports for distribution to low- and middle-income nations under the global vaccine-sharing programme COVAX.
Stay updated with breaking news from Covishield Export. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Covishield-maker Serum Institute of India has resumed vaccine exports for distribution to low- and middle-income nations under the global vaccine-sharing programme COVAX.
The first batches of its Covishield COVID-19 vaccine left the SII manufacturing facility in Pune on Friday, for distribution to low- and middle-income countries.
Serum Institute of India resumed Covishield export under Covax on Friday, as output surpassed 1 billion units.
The government recently permitted the export of 2 crore doses of COVID 19 vaccine Covovax produced in India by Serum Institute of India to Indonesia